Hansoh Pharmaceutical Group Co Registered Shares HD -,00001
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
6.50%
Market Cap
19.76 Bil.
P/E Ratio
35.71
Dividend Yield
1.20 %
Earnings per Share
0.11 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 3.258 G | 0 Units |
| PRICE DETERMINATION TIME | 06/19/2026 / 01:31:38 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 3.268 | 3.256 |
| PREV. DAY'S PRICE | 3.259 | (06/18) |
| CHANGE DAY BEFORE | -0.00 | -0.03 % |
| 52 WEEK HIGH / LOW | 4.8 (01/15) | 2.92 (06/19) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 0.14 | 0.13 | 0.11 | 0.09 | 0.07 |
| DIVIDENDS PER SHARE | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 |
| DIVIDEND YIELD IN % | - | - | 1.20 % | 1.95 % | 1.35 % |
| DIVIDEND GROWTH IN % | - | - | 23.17 % | 58.40 % | 107.12 % |
| PRICE - EARNINGS RATIO | 23.95 | 25.96 | 35.71 | 21.62 | 25.78 |
| PRICE - BOOK RATIO | - | - | 5.55 | 3.36 | 3.29 |
| PRICE - SALES RATIO | - | - | 13.24 | 7.73 | 8.50 |
| PRICE - CASH FLOW RATIO | - | - | 25.03 | 20.03 | 23.51 |
Master Data
| WKN | A2PLRC |
| ISIN | KYG549581067 |
| SYMBOL | 3KY |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | HANSOH PHARMAC. HD-,00001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Hong Kong Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 6.06 Bil. |
| MARKET CAPITALISATION | 19.76 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 3.49 % | -11.30 % | -10.96 % | -21.28 % | 6.50 % | 111.62 % | -4.15 % | -16.44 % |
| HIGH | 3.27 | 3.79 | 4.30 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
| LOW | 3.16 | 3.08 | 3.08 | 3.08 | 2.92 | 1.11 | 1.11 | 3.08 |
Dividend
per share
Company profile
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, CNS diseases; metabolic and other diseases. The company was founded by Hui Juan Zhong on December 2, 2015 and is headquartered in Shanghai, China.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.